Connect with us

Health

NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells – News-Medical.Net

Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and…

Published

on

Article feature image

Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
The findings were published today in Clinical Cancer Research, a journal of the American Association for Cancer Research. These results led to…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Third wave of Covid ‘definitely under way’ in UK, says expert – The Guardian
Best news stories 2021-06-19 – Medical Xpress